Jazz Pharmaceuticals plc Financial Flexibility Index
Jazz Pharmaceuticals plc financial flexibility index. Jazz Pharmaceuticals plc (J7Z) has a Financial Flexibility Index of 0.06x as of March 2026. Free cash flow of €427.90 Million (operating CF €408.20 Million minus capex €19.70 Million) represents 0% of total liabilities (€7.33 Billion). See cash generation quality of Jazz Pharmaceuticals plc to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Jazz Pharmaceuticals plc (2013–2025)
Financial flexibility index of Jazz Pharmaceuticals plc from 2013 to 2025. Historical Financial Flexibility Index trend for Jazz Pharmaceuticals plc across 13 annual periods. Check Jazz Pharmaceuticals plc earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Jazz Pharmaceuticals plc Financial Flexibility Index by Year (2013–2025)
Jazz Pharmaceuticals plc financial flexibility index by year from 2013 to 2025. Year-by-year free cash flow to debt coverage for Jazz Pharmaceuticals plc. For the full cash flow conversion analysis, see J7Z cash flow metrics.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.21x | €1.57 Billion | €1.36 Billion | €7.34 Billion | ▲ +17.0% |
| 2024 | 0.18x | €1.44 Billion | €1.40 Billion | €7.92 Billion | ▲ +23.0% |
| 2023 | 0.15x | €1.13 Billion | €1.09 Billion | €7.66 Billion | ▼ -11.7% |
| 2022 | 0.17x | €1.30 Billion | €1.27 Billion | €7.75 Billion | ▲ +73.5% |
| 2021 | 0.10x | €806.15 Million | €778.51 Million | €8.33 Billion | ▼ -69.6% |
| 2020 | 0.32x | €914.65 Million | €899.65 Million | €2.88 Billion | ▼ -5.4% |
| 2019 | 0.34x | €816.54 Million | €776.40 Million | €2.43 Billion | ▲ +0.4% |
| 2018 | 0.33x | €819.27 Million | €798.90 Million | €2.45 Billion | ▲ +11.8% |
| 2017 | 0.30x | €722.04 Million | €693.09 Million | €2.41 Billion | ▲ +13.1% |
| 2016 | 0.26x | €773.97 Million | €592.39 Million | €2.92 Billion | ▼ -19.1% |
| 2015 | 0.33x | €567.90 Million | €531.94 Million | €1.73 Billion | ▲ +45.2% |
| 2014 | 0.23x | €443.95 Million | €407.61 Million | €1.97 Billion | ▼ -28.7% |
| 2013 | 0.32x | €298.41 Million | €288.43 Million | €942.69 Million | — |